# To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

> **NCT02467322** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 80 (actual)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **DRUG:** Albumin
- **DRUG:** ascitic fluid

## Key facts

- **NCT ID:** NCT02467322
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-23
- **Primary completion:** 2016-12-15
- **Final completion:** 2016-12-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467322, "To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02467322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*